Minocycline Alone and in Combination with Polymyxin B, Meropenem, and Sulbactam against Carbapenem-Susceptible and -Resistant Acinetobacter baumannii in an In Vitro Pharmacodynamic Model-Reference-Cited by-同舟云学术

Minocycline Alone and in Combination with Polymyxin B, Meropenem, and Sulbactam against Carbapenem-Susceptible and -Resistant Acinetobacter baumannii in an In Vitro Pharmacodynamic Model

Published:2021-02-17 Issue:3 Volume:65 Page:
ISSN:0066-4804
Container-title:Antimicrobial Agents and Chemotherapy
language:en
Short-container-title:Antimicrob Agents Chemother

Author:

Beganovic Maya¹²,Daffinee Kathryn E.¹,Luther Megan K.¹²³,LaPlante Kerry L.¹²³⁴⁵^ORCID

Affiliation:

1. Infectious Diseases Research Program, Providence Veterans Affairs Medical Center, Providence, Rhode Island, USA

2. College of Pharmacy, University of Rhode Island, Kingston, Rhode Island, USA

3. Center of Innovation in Long-Term Support Services, Providence Veterans Affairs Medical Center, Providence, Rhode Island, USA

4. Division of Infectious Diseases, Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA

5. School of Public Health, Brown University, Providence, Rhode Island, USA

Abstract

Acinetobacter baumannii is recognized as an urgent public health threat by the Centers for Disease Control and Prevention (CDC). Current treatment options are scarce, particularly against carbapenem-resistant Acinetobacter baumannii (CRAB).

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Link

https://journals.asm.org/doi/pdf/10.1128/AAC.01680-20

Reference36 articles.

1. Antibiotic resistance threats in the United States, 2019

2. Current control and treatment of multidrug-resistant Acinetobacter baumannii infections

3. Nosocomial Bloodstream Infections in US Hospitals: Analysis of 24,179 Cases from a Prospective Nationwide Surveillance Study

4. Carbapenem resistance and mortality in patients with Acinetobacter baumannii infection: systematic review and meta-analysis

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of Hypervirulent and Non-Hypervirulent Carbapenem-Resistant Acinetobacter baumannii Isolated from Bloodstream Infections: Mortality, Potential Virulence Factors, and Combination Therapy In Vitro;Antibiotics;2024-08-26

2. Treatment of infections caused by carbapenem-resistant Acinetobacter baumannii;Frontiers in Cellular and Infection Microbiology;2024-07-18

3. Antimicrobial susceptibility and genetic characteristics of multi-drug resistant Acinetobacter baumannii isolates in Northwest China;Frontiers in Microbiology;2024-04-30

4. Successful Treatment of Carbapenem-Resistant Acinetobacter baumannii Meningitis With Sulbactam-Durlobactam;Clinical Infectious Diseases;2024-04-17

5. Clinical characteristics and antimicrobial therapy of healthcare-associated carbapenem-non-susceptible gram-negative bacterial meningitis: a 16-year retrospective cohort study;BMC Infectious Diseases;2024-04-02